U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
ILADATUZUMAB
INN  
Official Name English
iladatuzumab [INN]
Preferred Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN GENE B29 PROTEIN (CD79B ANTIGEN))(HUMAN-MUS MUSCULUS MONOCLONAL MCDS0593A .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL MCDS0593A .KAPPA.-CHAIN, DIMER
Common Name English
RG7986
Common Name English
Code System Code Type Description
CAS
1906205-76-2
Created by admin on Mon Mar 31 22:55:55 GMT 2025 , Edited by admin on Mon Mar 31 22:55:55 GMT 2025
PRIMARY
FDA UNII
K30KZ4TQ5Y
Created by admin on Mon Mar 31 22:55:55 GMT 2025 , Edited by admin on Mon Mar 31 22:55:55 GMT 2025
PRIMARY
SMS_ID
300000042602
Created by admin on Mon Mar 31 22:55:55 GMT 2025 , Edited by admin on Mon Mar 31 22:55:55 GMT 2025
PRIMARY
INN
10646
Created by admin on Mon Mar 31 22:55:55 GMT 2025 , Edited by admin on Mon Mar 31 22:55:55 GMT 2025
PRIMARY
NCI_THESAURUS
C170054
Created by admin on Mon Mar 31 22:55:55 GMT 2025 , Edited by admin on Mon Mar 31 22:55:55 GMT 2025
PRIMARY
ACTIVE MOIETY
ILADATUZUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966